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Hip arthroplasty in young patients requires thoughtful preoperative planning. Patients with proximal
femoral bone loss complicate this planning and may require a staged procedure to optimize implant
insertion. We report on a case of a 26-year-old woman with secondary hip arthritis from developmental
dysplasia of the hip and a large pertrochanteric bone cyst that was treated with staged total hip
arthroplasty. The cyst was decompressed and ﬁlled with an osteoconductive and osteoinductive bone
graft substitute called EquivaBone. One year later, the patient underwent a successful primary total hip
arthroplasty. Fifteen-month follow-up after her hip replacement revealed resolution of postoperative
pain and signiﬁcant functional improvement.
Copyright © 2016 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Total hip arthroplasty (THA) became popularized in the 1960s by
Sir John Charnley for the purpose of relieving pain and restoring
function in elderly patients with degenerative hip arthritis [1,2].
Over time, the indications have broadened to include young adults
with severe degenerative changes secondary to various pediatric
hip disorders; in these patients, success rates are excellent [3-9].
When performing arthroplasty in this young patient population,
the treating surgeon must consider the need for eventual revision
arthroplasty, as younger age and higher activity are thought to
contribute to increased wear and risk of revision surgery [8,9]. An
ideal implant in this young patient population would be a proxi-
mally loading tapered femoral stem, as it avoids proximal stress
shielding and allows for preservation of more distal bone stock
should revision surgery be required [10]. However, fundamental toclosed potential or pertinent
ent, either direct or indirect,
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es/by-nc-nd/4.0/).the stability of this type of implant is strong metaphyseal bone that
would allow for rigid ﬁxation and biologic ingrowth [10,11].
We present a case of a 26-year-old femalewith severe secondary
hip arthritis due to developmental hip dysplasia, who presents
with a slowly enlarging pertrochanteric bone cyst. The lesion was
decompressed and ﬁlled with a new biological bone graft substi-
tute, EquivaBone (ETEX, Cambridge, MA), to allow for restoration of
bone stock in her proximal femur as part of a staged THA.Case history
The patient ﬁrst presented to adult reconstruction clinic seeking
evaluation for a left hip pain at the age of 23 years. The patient
provided full consent for use of this case for research purposes and
publication. She has history of developmental dysplasia of her left
hip, which was ﬁrst dislocated at the age of 4 months. She also has a
positive family history of Legg-Calve-Perthes disease. Before the
age of 6 months, she underwent open reduction and hip spica
casting, which was successful in obtaining a reduction. However, at
the age of 3, a Salter osteotomywas performed to provide improved
femoral head coverage for her dysplastic hip. She did relatively well
for several years but began having increasing amounts of hip pain
during daily activity in her mid- to late-teenage years. She was
indicated for a periacetabular osteotomy (PAO) at the age of 20
years. A left hip arthroscopy was performed before this to evaluate
the integrity of her cartilage, which was found to be so damagedan Association of Hip and Knee Surgeons. This is an open access article under the CC
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options for her left hip short of an arthroplasty or arthrodesis.
When seen in our clinic at the age of 23, she had functional hip
painwithmost daily activities. On physical examination, her left leg
was approximately 1-cm shorter than her right by block testing.
She had a 15 degree left hip ﬂexion contracture, with passive range
of motion to 95 degrees ﬂexion, 10 degrees external rotation, and 5
degrees internal rotation. Radiographs at this time (Fig. 1a) showed
markedly aspherical left femoral head and an eroded acetabular
articular surface with severe joint space narrowing, subchondral
sclerosis, and cysts, with underlying acetabular dysplasia and
postosteotomy deformity. Notably, lateral center-edge ankle of the
left hip measured 0 degrees. Her right hip was also mildly
dysplastic with a lateral center-edge angle of 23 degrees; however,
she reported no pain so no further work-up or intervention was
pursued.
It was discussed that her gender and dysplastic anatomy make
her a poor candidate for hip resurfacing given her higher risk of
complications. A PAO was again considered an option but a mag-
netic resonance arthrogram obtained several weeks later (Fig. 2)Figure 1. Serial anteroposterior and lateral left hip radiographs reveal aspherical left femor
subchondral sclerosis and cysts, and underlying acetabular dysplasia and postosteotomy defo
old (a), 25 years old (b), and 26 years old (c; 9 months after cyst curretage and grafting). The
her proximal femoral metaphysis.demonstrated signiﬁcant chondral damage on both the femoral and
acetabular surfaces as well as a large pertrochanteric simple bone
cyst. She was thus instructed that her best surgical optionwould be
a THA but that she should delay as long as possible due to the high
likelihood of requiring revision surgery during her life. The patient
agreed to pursue our conservative treatment plan as long as she
could tolerate the pain.
Over the next 2 years she had slowly progressive pain and
increased functional limitations, walking with a Trendelenburg
gait. She had several intra-articular corticosteroid injections that
provided moderate relief for 2-4 months but with diminishing
returns as she progressed. Serial radiographs demonstrated pro-
gression of her pertrochanteric bone cyst (Fig. 1b). Several discus-
sions had occurred regarding this cyst affecting the quality of
proximal femoral bone stock. The concern was that her abnormal
osseous architecture would not be strong enough to support a
proximally loading femoral implant and that she would require
a fully porous coated implant with diaphyseal ﬁxation. Although a
suitable choice of ﬁxation, this type implant is less ideal as it would
threaten more signiﬁcant bone loss should she ever requireal head and an eroded acetabular articular surface with severe joint space narrowing,
rmity. The images, in order from left to right, were takenwhen the patient was 23 years
pertrochanteric cyst appeared to show graft incorporation and osseous remodeling of
Figure 2. Coronal T1 and axial T2 images of an magnetic resonance arthrogram demonstrating a large bone cyst measuring 8  3  3 cm in the proximal femur. MRA, magnetic
resonance arthrogram.
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her age. Because shewas interested in undergoing a THA in the near
future, the decisionwasmade to undergo cyst decompression and a
bone grafting procedure to restore the osseous integrity of her
proximal femur as the ﬁrst part of a staged arthroplasty.
In June 2011, she underwent curettage and bone grafting of her
pertrochanteric cyst, whichmeasured 8 3 3 centimeters. A burr
was used to make a small lateral cortical window, to which a
curette was inserted and used for cyst decompression. Subse-
quently, 40 cc of EquivaBone, an osteoconductive and osteoinduc-
tive bone graft substitute, was then injected into the defect. This
procedure went without complication.
She was closely followed at regular clinic visits with repeat
radiographs to evaluate for osseous incorporation of EquivaBone
into the previous lesion. She was ambulating pain free without an
assistive device several weeks after her procedure, reporting
improved functional abilities when compared to before her surgery.
Radiographs at 9 months postoperatively showed bone graft
incorporation and osseous remodeling in her left pertrochanteric
region (Fig. 1c). As time progressed, her left hip became more
symptomatic and she was indicated to undergo THA with an
uncemented proximally loading femoral implant.
THA was performed in June 2012 through a posterior approach
using standard primary arthroplasty implants (Zimmer Continuum
acetabular shell, Zimmer trabecular metal femoral stem with
standard offset, and Biolox delta ceramic femoral head). During the
operation, the acetabulum was found to have severe superolateral
bone loss from the pseudosubluxation and coxa magna of the
femoral head. To optimize bony contact with the acetabular
implant, the cup was placed in a slightlymore vertical position than
typically desired. The abduction angle measures 60 degrees from
the horizontal. This cup position may predispose to increased
polyethylenewear due to the potential for edge loading; however, a
10 degree elevated hood liner was placed superolaterally to miti-
gate this risk.
After the femoral neck cut was made and on investigation of the
medullary bone, complete ingrowth of the EquivaBone (placed 1
year prior) was achieved. The cancellous bonewasmore dense than
usual and there was some difﬁculty passing the canal ﬁnder,
although it was still safely accomplished under manual pressure.
Based on the postoperative radiographs, the femoral component
does appear to be undersized on the anteroposterior view, but webelieve this is due to the underlying proximal femoral dysplasia.
After ﬁnal broaching and placement of the implant, a strong press
ﬁt was accomplished with medial calcar contact, and there was
excellent torsional stability. On the lateral radiograph, the compo-
nent appears to be well sized within the femur.
Within 2 months post THA and 14 months after bone grafting of
the metaphyseal cyst, she was completely pain free in her left hip
and able to walk several miles without pain. Four months after THA
and 16months after bone grating, the patient continued to progress
well and was able to work out at her gym, reporting only minimal
discomfort with leg presses. She was 4 weeks pregnant at this visit;
however, she was unaware that she had conceived. Radiographs
showed a well positioned implant with evidence of osseous inte-
gration into the implant, without subsidence or signs of osteolysis
(Fig. 3a). Her hip ﬂexion contracture had resolved and hip range of
motion was painless, ranging from 0 degrees extension to 120
degrees ﬂexion, 40 degrees internal rotation, and 30 degrees
external rotation.
At 15 months after her THA and 2 months post partum with an
uncomplicated vaginal delivery, her left hip remained pain free. She
reported no problems with her hip and felt that she was not limited
in any way. Her Trendelenburg gait had resolved and her range of
motion was 0 degrees hip extension, 100 degrees of ﬂexion, 50
degrees internal rotation, 40 degrees of external rotation. Her
Harris Hip Score was 100. Radiographs revealed a stable implant,
unchanged from prior imaging (Fig. 3b). The plan is to follow her
every 2 years for surveillance.Discussion
THA has been successfully used in young adults for multiple
end-stage pediatric hip disorders including osteonecrosis, inﬂam-
matory arthroses, post-traumatic arthritis, developmental hip
dysplasia, Legg-Calve-Perthes disease, slipped capital femoral
epiphysis, multiple epiphyseal dysplasia, and several other condi-
tions [3-9]. However, when planning the primary arthroplasty,
surgeons should consider multiple factors with respect to the need
for future revision surgery during the patient’s lifetime: implant
material, bearing surface, bone quality, and so forth. One additional
factor is the preservation of remaining femoral and acetabular bone
stock, which is commonly abnormal and/or deﬁcient in these
pediatric deformities.
Figure 3. Anteroposterior pelvis and frog-leg lateral left hip (a) taken 4 months after THA and (b) 15 months after her THA. Radiographs demonstrate evidence of component
integration without subsidence or signs of osteolysis.
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several reasons. According toWolfe's law, increases in load result in
maintenance of bone mass and an increase in the qualitative and
quantitative bone properties. Thus, a proximally loading implant
with rigid ﬁxation maintains the proximal bone stock and avoids
proximal stress shielding, osteopenia, and bone resorption [10,12].
In addition, it obviates the need for diaphyseal ﬁxation, which not
only leads to the aforementioned problem of proximal stress
shielding but can result in signiﬁcant iatrogenic bone loss during
implant removal in the setting of revision surgery. A requirement for
a proximally loading femoral stem is adequate proximal bone stock
to allow for rigid ﬁxation and biologic ingrowth. This concept of
initial rigid ﬁxation is well established in the arthroplasty literature,
with a goal of <50 microns of micromotion at the implantdcortical
bone interface [10-12]. Fixation of this strength allows osseous
ingrowth and provides stability against the axial and rotational
forces of daily living and leads to a greater likelihood of successful
arthroplasty. However, use of a proximally loading implant in a fe-
mur with insufﬁcient osseous integrity would have a greater risk of
increased stem micromotion, ﬁbrous ingrowth, instability to
torsional and axial forces, and eventual implant failure.
The case presented in this report is a young adult with inade-
quate proximal bone stock due to a large bone cyst. THA with anuncemented, proximally loading stem would be at high risk of
failure in this setting, as her bone quality would likely be unable to
provide for stable, biologic ﬁxation against the forces acting on it.
We, therefore, had to ﬁll her osseous defect and to allow future
successful arthroplasty implantation.
In the presence of osseous defects during hip arthroplasty, the
surgeon can choose to ﬁll the void with autograft, allograft chips, or
one of several bone graft substitutes. Each has its own advantages
and disadvantages, with varying amounts of strength and osteo-
genic potential [10,13,14]. The ideal graft would have a combination
of both osteoconductive and osteoinductive properties and would
allow for restoration of osseous architecture for future ingrowth
into the arthroplasty component. Much research has focused on the
use of morselized bone graft, with or without augmentation of
bioceramics such as hydroxyapatite or tricalciumphosphate, in
cases of femoral or acetabular component revision arthroplasty
[10,15-18]. However, there is little information on the efﬁcacy and
use of bone graft or bone graft substitute to restore bone stock for
primary THA.
EquivaBone (ETEX) is a new US Food and Drug
Administrationeapproved hard-setting osteoinductive bone graft
substitute combined with an osteoconductive nanocrystalline
calcium phosphate scaffold. Its composition of calcium phosphate
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similar to bone remodeling through osteoclast resorption [19].
When compared to cancellous bone grafts and other bone graft
substitutes, calcium phosphate is known to have a much higher
compressive strength which provides stable ﬁxation [19]. However,
it has unique osteoinductive properties as well, which signal host
stem cells to differentiate along osteoblastic lines [19,20]. Because
of these properties, we used this bone graft substitute to ﬁll the
cystic cavity in the proximal femur, as we felt it would provide the
best opportunity for osseous regrowth. And as expected, radio-
graphs over the next year showed remodeling of her proximal
femur and bone graft incorporation, strong enough to support THA
with a proximally loading, tapered femoral stem just one year later.
Summary
Proximal femoral bone loss is a complicated problem for
patients planning to undergo hip replacement. This is compounded
in young patients where the use of proximally loaded press ﬁt
femoral stems are greatly preferred due to their biomechanical
properties and risk of future revision. To our knowledge, this is the
ﬁrst description of EquivaBone in the arthroplasty literature. Based
on its biological and mechanical properties, and successful use in
this case report, we feel that EquivaBone merits further study as a
potential bone graft substitute in cases of THA. Future studies with
a larger number of patients, long-term follow-up, and osseous
defects in a variety of acetabular and femoral locations should be
evaluated.
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